BackChina Jo-Jo Drugstores Overview
China Jo-Jo Drugstores Inc

China Jo-Jo Drugstores Debt to Equity

China Jo-Jo Drugstores (CJJD) has a debt-to-equity ratio of 1.96, above the Healthcare sector average of 0.31.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

1.96

Debt to Equity

1.96

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

China Jo-Jo Drugstores (CJJD) FAQ

The latest debt-to-equity ratio for CJJD is 1.96. That is above the Healthcare sector average of 0.31. Investors often review this figure alongside China Jo-Jo Drugstores's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, CJJD currently prints 1.96 for debt-to-equity ratio, while the sector average sits near 0.31. That is roughly 537.0% above the sector mean. Large gaps often invite a closer look at China Jo-Jo Drugstores's growth, margins, and balance sheet.

A debt-to-equity ratio of 1.96 for China Jo-Jo Drugstores is not 'good' or 'bad' on its own. Compare it with the peer average (0.31) and with CJJD's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting CJJD's debt-to-equity ratio (1.96), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack China Jo-Jo Drugstores's debt-to-equity ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.